AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...
The 13th meeting of the Russian-Arab Business Council session was held on 25-26 January.
Russia's pharmaceutical industry has managed not only to adapt to the...
Argentina has displayed an interest in the nasal form of Russia's Sputnik V coronavirus vaccine and other Russian developments for treating and preventing COVID-19,...
The Gamaleya Institute is ready to file papers to Russian Health Ministry to obtain permission for research of new platforms for COVID vaccines, Institute...